Axolabs Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 185

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

Axolabs General Information

Description

Developer of therapeutic nucleic acids catering to the oligonucleotide therapeutics market. The company's line of services includes lead identification, cell-based assays, protein analysis, bioanalytics, manufacturing, bioinformatics, function delivery and gene editing.

Contact Information

Website
www.axolabs.com
Formerly Known As
Roche Kulmbach, Ribopharma
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Fritz-Hornschuch-Straße 9
  • 95326 Kulmbach
  • Germany
+49 09221
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Parent Company
LGC
Vertical(s)
Life Sciences
Corporate Office
  • Fritz-Hornschuch-Straße 9
  • 95326 Kulmbach
  • Germany
+49 09221

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axolabs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axolabs‘s full profile, request access.

Request a free trial

Axolabs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic nucleic acids catering to the oligonucleotide therapeutics market. The company's line of servic
Drug Discovery
Kulmbach, Germany
185 As of 2023

Zug, Switzerland
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axolabs Competitors (53)

One of Axolabs’s 53 competitors is CRISPR Therapeutics, a Formerly VC-backed company based in Zug, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Precision BioSciences Formerly VC-backed Durham, NC
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
ToolGen Corporation Seoul, South Korea
Editas Medicine Formerly VC-backed Cambridge, MA
You’re viewing 5 of 53 competitors. Get the full list »

Axolabs Patents

  • 210

    Total Documents Applications and Grants

  • Total Patents Families

  • 92

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

Axolabs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230095695-A1 Rnas for complement inhibition Pending 14-Feb-2020
US-20230287406-A1 Multimeric oligonucleotides with enhanced bioactivity Pending 04-Mar-2019
EP-3802819-A1 Method for detecting oligonucleotide conjugates Pending 30-May-2018
US-20210207123-A1 Method for detecting oligonucleotide conjugates Inactive 30-May-2018
CA-3101867-A1 Method for detecting oligonucleotide conjugates Pending 30-May-2018 C12N15/101
To view Axolabs’s complete patent history, request access »

Axolabs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axolabs Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Axolabs‘s full profile, request access.

Request a free trial

Axolabs FAQs

  • When was Axolabs founded?

    Axolabs was founded in 2000.

  • Where is Axolabs headquartered?

    Axolabs is headquartered in Kulmbach, Germany.

  • What is the size of Axolabs?

    Axolabs has 185 total employees.

  • What industry is Axolabs in?

    Axolabs’s primary industry is Drug Discovery.

  • Is Axolabs a private or public company?

    Axolabs is a Private company.

  • What is Axolabs’s current revenue?

    The current revenue for Axolabs is .

  • Who are Axolabs’s investors?

    Alnylam Pharmaceuticals and Roche have invested in Axolabs.

  • Who are Axolabs’s competitors?

    CRISPR Therapeutics, Precision BioSciences, Adverum Biotechnologies, ToolGen, and Editas Medicine are some of the 53 competitors of Axolabs.

  • When was Axolabs acquired?

    Axolabs was acquired on 03-Apr-2017.

  • Who acquired Axolabs?

    Axolabs was acquired by LGC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »